Daniel G. Baker - 28 Jan 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTV	Director Stock Option (Right to Buy)	Award	$0	+27,500		$0.000000	27,500	28 Jan 2025	Common Stock	27,500	$5.56	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following January 28, 2025,